半胱胺:修订间差异
删除的内容 添加的内容
无编辑摘要 |
无编辑摘要 |
||
第4行: | 第4行: | ||
<!-- Pharmacokinetic data -->|bioavailability=|protein_bound=|metabolism=|metabolites=|onset=|elimination_half-life=|duration_of_action=|excretion=<!-- Identifiers -->|CAS_number=60-23-1|CAS_supplemental={{cascite|correct|CAS}}|ATCvet=|ATC_prefix=<!-- 'none' if uncategorised -->|ATC_suffix=|ATC_supplemental=|PubChem=6058|PubChemSubstance=|IUPHAR_ligand=7440|DrugBank=DB00847|ChemSpiderID=5834|UNII=5UX2SD1KE2|KEGG=D03634|ChEBI=17141|ChEMBL=602|NIAID_ChemDB=|synonyms=2-Aminoethanethiol<br />''β''-Mercaptoethylamine<br />2-Mercaptoethylamine<br />Decarboxycysteine<br />Thioethanolamine<br />Mercaptamine |
<!-- Pharmacokinetic data -->|bioavailability=|protein_bound=|metabolism=|metabolites=|onset=|elimination_half-life=|duration_of_action=|excretion=<!-- Identifiers -->|CAS_number=60-23-1|CAS_supplemental={{cascite|correct|CAS}}|ATCvet=|ATC_prefix=<!-- 'none' if uncategorised -->|ATC_suffix=|ATC_supplemental=|PubChem=6058|PubChemSubstance=|IUPHAR_ligand=7440|DrugBank=DB00847|ChemSpiderID=5834|UNII=5UX2SD1KE2|KEGG=D03634|ChEBI=17141|ChEMBL=602|NIAID_ChemDB=|synonyms=2-Aminoethanethiol<br />''β''-Mercaptoethylamine<br />2-Mercaptoethylamine<br />Decarboxycysteine<br />Thioethanolamine<br />Mercaptamine |
||
<!-- Chemical and physical data -->|chemical_formula=|C=2|H=7|Ag=|Al=|As=|Au=|B=|Bi=|Br=|Ca=|Cl=|Co=|F=|Fe=|Gd=|I=|K=|Li=|Mg=|Mn=|N=1|Na=|O=|P=|Pt=|S=1|Sb=|Se=|Sr=|Tc=|Zn=|charge=|molecular_weight=|SMILES=|StdInChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2|StdInChI_Ref={{stdinchicite|correct|chemspider}}|StdInChIKey=UFULAYFCSOUIOV-UHFFFAOYSA-N|density=|density_notes=|melting_point=95 to 97|melting_high=|melting_notes=|boiling_point=|boiling_notes=|solubility=|specific_rotation=}} |
<!-- Chemical and physical data -->|chemical_formula=|C=2|H=7|Ag=|Al=|As=|Au=|B=|Bi=|Br=|Ca=|Cl=|Co=|F=|Fe=|Gd=|I=|K=|Li=|Mg=|Mn=|N=1|Na=|O=|P=|Pt=|S=1|Sb=|Se=|Sr=|Tc=|Zn=|charge=|molecular_weight=|SMILES=|StdInChI=1S/C2H7NS/c3-1-2-4/h4H,1-3H2|StdInChI_Ref={{stdinchicite|correct|chemspider}}|StdInChIKey=UFULAYFCSOUIOV-UHFFFAOYSA-N|density=|density_notes=|melting_point=95 to 97|melting_high=|melting_notes=|boiling_point=|boiling_notes=|solubility=|specific_rotation=}} |
||
'''2-氨基乙硫醇'''是一种用于治疗多种疾病的药物,经[[FDA]]批准用于治疗[[胱氨酸症]],可口服或作为滴眼液成分。<ref name=USlabelExtcapsules>{{cite web|title=US Label: Cysteamine bitartrate delayed-release capsules|url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/203389s010lbl.pdf|publisher=FDA|date=August 2015}}</ref><ref name=USlabelCapsules>{{cite web|title=US Label: Cysteamine bitartrate capsules|url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2007/020392s010lbl.pdf|publisher=FDA|date=June 2007}}</ref><ref name=USlabelEye>{{cite web|title=US Label: Cysteamine ophthalmic solution|url=http://www.accessdata.fda.gov/drugsatfda_docs/label/2012/200740s000lbl.pdf|publisher=FDA|date=October 2012}}</ref><ref>{{cite journal|last1=Shams|first1=F|last2=Livingstone|first2=I|last3=Oladiwura|first3=D|last4=Ramaesh|first4=K|title=Treatment of corneal cystine crystal accumulation in patients with cystinosis.|journal=Clinical Ophthalmology (Auckland, N.Z.)|date=10 October 2014|volume=8|pages=2077–84|pmid=25336909|pmc=4199850|doi=10.2147/OPTH.S36626}}</ref> |
|||
'''2-氨基乙硫醇'''是一种用于治疗多种疾病的药物,经[[FDA]]批准用于治疗[[胱氨酸症]]。 |
|||
[[Category:罕用药]] |
[[Category:罕用药]] |
||
[[Category:硫醇]] |
[[Category:硫醇]] |
2019年6月25日 (二) 22:49的版本
Skeletal formula (top) Ball-and-stick model of the cysteamine | |
臨床資料 | |
---|---|
其他名稱 | 2-Aminoethanethiol β-Mercaptoethylamine 2-Mercaptoethylamine Decarboxycysteine Thioethanolamine Mercaptamine |
核准狀況 | |
识别信息 | |
| |
CAS号 | 60-23-1( ) |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.000.421 |
化学信息 | |
化学式 | C2H7NS |
摩尔质量 | 77.15 g·mol−1 |
熔点 | 95至97 °C(203至207 °F) |
|
2-氨基乙硫醇是一种用于治疗多种疾病的药物,经FDA批准用于治疗胱氨酸症,可口服或作为滴眼液成分。[1][2][3][4]
- ^ US Label: Cysteamine bitartrate delayed-release capsules (PDF). FDA. August 2015.
- ^ US Label: Cysteamine bitartrate capsules (PDF). FDA. June 2007.
- ^ US Label: Cysteamine ophthalmic solution (PDF). FDA. October 2012.
- ^ Shams, F; Livingstone, I; Oladiwura, D; Ramaesh, K. Treatment of corneal cystine crystal accumulation in patients with cystinosis.. Clinical Ophthalmology (Auckland, N.Z.). 10 October 2014, 8: 2077–84. PMC 4199850 . PMID 25336909. doi:10.2147/OPTH.S36626.